Market Tracker

07/30 6:05pm ET

Amgen Inc (NASDAQ:AMGN)

During the Trading Day
130.01 +6.70 / +5.43%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
130.00 -0.01 / -0.01%
 
Volume: 80.3K

Today’s Trading

Previous close123.31
Today’s open128.63
Day’s range128.63 - 131.24
Volume8,465,651
Average volume (3 months)2,874,480
Market cap$93.3B
Dividend yield1.88%
Data as of 3:59pm ET, 07/30/2014

Growth & Valuation

Earnings growth (last year)+20.29%
Earnings growth (this year)+6.49%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+8.61%
P/E ratio21.1
Price/Sales4.60
Price/Book4.21

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen Idec Inc+2.79+0.82%
GILDGilead Sciences Inc+0.80+0.86%
BAXBaxter International...-0.25-0.33%
GRFSGrifols SA-0.03-0.07%
Data as of 4:00pm ET, 07/30/2014

Financials

Last reporting dateJuly 30, 2014
EPS forecast (this quarter)$2.07
Annual revenue (last year)$18.7B
Annual profit (last year)$5.1B
Net profit margin27.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhu Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts